Duquesne Nanomedicine Lab Making Big Strides with Tiny Particles
PITTSBURGH, March 6, 2025 /PRNewswire/ -- Duquesne University's Nanomedicine Manufacturing Laboratory (NML) is taking tiny particles and using them to...
DNA
HyBryte™ Treatment Studies Presented at Two Medical Conferences in March
Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6,...
St. Baldrick’s Foundation Awards $1.4 Million in Fellowships to Advance Childhood Cancer Research
Los Angeles, California--(Newsfile Corp. - March 6, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer...
NIIMBL Announces RFA for Optimizing Long-read Next-generation Sequencing Capabilities
NEWARK, Del., March 4, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce...
IDENTIFYSENSORS RAISES $20 MILLION TO ADVANCE NEW DIGITAL DIAGNOSTICS PLATFORM
CLEVELAND, March 3, 2025 /PRNewswire/ -- IdentifySensors Biologics, a leading developer of digital diagnostic technologies, has raised $20 million to...
Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq Rules
BOSTON and LONDON, March 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision...
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
BERKELEY, Calif. and MAINZ, Germany, March 03, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),...
Connect Biopharma to Present at Two Upcoming Investor Conferences
SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a...
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
- Greatly improved patient quality of life and reduced disease impact in patients with CSU and CIndU -- 82% of...
4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial...
Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates
-- On track to report initial data from Phase 1/2 clinical trial of PM359 for p47phox CGD in 2025 --...
LA FIRE VICTIMS CAN RELEASE SOME OF THE STRESS: NUCALM AND TONY ROBBINS JOIN FORCES TO GIVE BACK
NuCalm Donates One-Year Membership to their Mobile App to Help Families Heal from the Trauma of Loss and Displacement WILMINGTON,...
Ubie and Nucleus Genomics Partner to Enhance Access to Genetic Testing and Drive Early Screening for Improved Health Outcomes
Genetic testing can be critical to ensuring the early diagnosis and proper treatment of serious disease for patients of all...
Rakovina Therapeutics and Variational AI Strengthen Partnership
Strategic Funding Led by Nimbus Synergies, Backed by Merck GHI, to Accelerate AI-Powered CollaborationsVANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE...
IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to...
Korro to Present at the TD Cowen 45th Annual Health Care Conference
CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on...
Aspargo Labs Appoints Mario Guralnik as Chief Regulatory Officer
Accomplished regulatory affairs veteran to lead company’s global regulatory strategy and drug product developmentNEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE)...
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results
Ginkgo provides update on its restructuring process including significant improvement in cash flow in the fourth quarter, completion of site...
Discovery Life Sciences Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con in San Diego
Global Biospecimen Leader to Unveil Transformative Tool for Oncology Studies HUNTSVILLE, Ala., Feb. 25, 2025 /PRNewswire/ -- Discovery Life Sciences...
Nucleus Genomics Hires Romain Daguet, Award-Winning Founder and Engineer
Investment in engineering team signals Nucleus' commitment to innovation and putting comprehensive health data in the hands of users NEW...